Research advances in inflammatory markers in predicting the prognosis of patients with HBV-related acute-on-chronic liver failure
10.3969/j.issn.1001-5256.2022.10.028
- VernacularTitle:炎性相关标志物判断HBV相关慢加急性肝衰竭预后的研究进展
- Author:
Tingting DENG
1
;
Li LI
2
;
Ying GUAN
1
;
Xueyan LUO
1
;
Kun QIN
1
;
Min LIU
1
Author Information
1. The First Clinical Institute, Zunyi Medical University, Zunyi, Guizhou 563000, China
2. The First Clinical Institute, Zunyi Medical University, Zunyi, Guizhou 563000, China;Department of General Medicine, Qianxinan Affiliated Hospital of Zunyi Medical University, Xingyi, Guizhou 562400, China
- Publication Type:Reviews
- Keywords:
Hepatitis B Virus;
Acute-On-Chronic Liver Failure;
Biomarkers;
Prognosis
- From:
Journal of Clinical Hepatology
2022;38(10):2346-2351
- CountryChina
- Language:Chinese
-
Abstract:
Acute-on-chronic liver failure (ACLF) is a clinical syndrome with short-term rapid deterioration, multiple organ failure, and high mortality and has become a research hotspot in the field of severe liver diseases. Early, accurate, and quick judgment of clinical prognosis and timely intervention of disease progression are of great significance for improving disease outcome. This article summarizes the inflammation-related prognostic markers for HBV-related ACLF found in recent years, so as to improve the existing prognostic indicators and provide more basis for evaluating the prognosis of ACLF patients by clinicians.
